A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtri
about
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtri
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase IV, Open-label, Random ...... Elvitegravir/Cobicistat/Emtri
@en
type
label
A Phase IV, Open-label, Random ...... Elvitegravir/Cobicistat/Emtri
@en
prefLabel
A Phase IV, Open-label, Random ...... Elvitegravir/Cobicistat/Emtri
@en
P4844
P1476
A Phase IV, Open-label, Random ...... fovir Alafenamide. DREAM Study
@en
P17
P1813
DREAM
@en
P3098
NCT03067285
P580
2017-09-08T00:00:00Z
P582
2019-06-01T00:00:00Z